ArticleCancer immunology, immunotherapy : CII2024

Multi-omics analysis and response prediction of PD-1 monoclonal antibody containing regimens in patients with relapsed/refractory diffuse large B-cell lymphoma.

Xinrui Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.